Cargando…

Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab

BACKGROUND: Systemic sclerosis (SSc) patients often need immunosuppressive medication (IS) for disease control. If SSc is progressive despite IS, autologous hematopoietic stem cell transplantation (aHSCT) is a treatment option for selected SSc patients. aHSCT is effective with good available evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gernert, Michael, Tony, Hans-Peter, Fröhlich, Matthias, Schwaneck, Eva Christina, Schmalzing, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801940/ https://www.ncbi.nlm.nih.gov/pubmed/35111167 http://dx.doi.org/10.3389/fimmu.2021.817893

Ejemplares similares

Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation
por: Gernert, Michael, et al.
Publicado: (2020)

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021)

Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern
por: Gernert, Michael, et al.
Publicado: (2019)

Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune Encephalitis
por: Froehlich, Matthias, et al.
Publicado: (2020)

Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication
por: Gernert, Michael, et al.
Publicado: (2021)

Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney disease
por: Strunz, Patrick-Pascal, et al.
Publicado: (2023)

High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary Immunodeficiencies
por: Gernert, Michael, et al.
Publicado: (2021)

Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
por: Gernert, Michael, et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
por: Schmalzing, Marc, et al.
Publicado: (2018)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020)

NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: Ruder, Josefine, et al.
Publicado: (2021)

Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
por: Gressenberger, Paul, et al.
Publicado: (2021)

Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions
por: Heim, Jana, et al.
Publicado: (2021)

A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: van Megen, Kayleigh M., et al.
Publicado: (2018)

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
por: Darlington, Peter J., et al.
Publicado: (2018)

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018)

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
por: Cencioni, Maria Teresa, et al.
Publicado: (2022)

The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study
por: Wei, Xiya, et al.
Publicado: (2022)

CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation
por: Heck, Clarissa, et al.
Publicado: (2021)

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021)

Case report: A successful second autologous hematopoietic stem cell transplantation in refractory systemic sclerosis, with positive effect on skin involvement, pulmonary function and microcirculation
por: Haverkort, D.A., et al.
Publicado: (2022)

Editorial: Stem cell transplantation in autoimmune diseases (AID)
por: Schmalzing, Marc, et al.
Publicado: (2023)

Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing Polychondritis
por: Veldkamp, Saskia R., et al.
Publicado: (2022)

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: Malmegrim, Kelen C. R., et al.
Publicado: (2017)

Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations
por: Świerzko, Anna S., et al.
Publicado: (2020)

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2020)

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
por: Bowen, James D., et al.
Publicado: (2011)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: von Niederhäusern, Valentin, et al.
Publicado: (2022)

Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
por: Froehlich, Matthias, et al.
Publicado: (2023)

Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma
por: Di Lullo, Giulia, et al.
Publicado: (2019)

Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis−associated aplastic anemia
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pqu66h0119t1g96s4t8rmqte4t